Author Question: A patient has taken perphenazine (Prolixin) for a year. The nurse observes lip smacking and grinding ... (Read 40 times)

silviawilliams41

  • Hero Member
  • *****
  • Posts: 560
A patient has taken perphenazine (Prolixin) for a year. The nurse observes lip smacking and grinding teeth. Which tool should the nurse use to complete the assessment?
 
  a. AIMS
  b. EPSE
  c. SAD PERSONS
  d. CAGE questionnaire

Question 2

After a patient's first group session, the nurse asks, How was the experience of participating in group for you? Which communication technique is the nurse using?
 
  a. Summarizing
  b. Seeking clarification
  c. Making observations
  d. Encouraging evaluation



IAPPLET

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

A
AIMS is the Abnormal Involuntary Movement Scale. It was developed to screen for tardive dyskinesia. EPSE refers to extrapyramidal side effects. The other tools are for assessing alcohol abuse and suicidality.

Answer to Question 2

D
Distinguishing among the techniques listed shows that the nurse is encouraging evaluation when asking a patient to make a judgment about the experience. This opens the door to further exploration of thoughts and feelings.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library